Centocor staggered by poor clinical results.
Gershon
D
D
D000911:Antibodies, Monoclonal / Q000009:adverse effects* / Q000633:toxicity; D061067:Antibodies, Monoclonal, Humanized; D001709:Biotechnology / Q000191:economics*; D017326:Clinical Trials, Phase III as Topic; D003643:Death; D005060:Europe; D006801:Humans; D007075:Immunoglobulin M / Q000009:adverse effects*; D012449:Safety; D014481:United States
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D007075:Immunoglobulin M; C068069:nebacumab